Mobile Site ›
Normal View

Test ID: FNEU
Neurotransmitter Metabolites/Amines

Secondary ID A test code used for billing and in test definitions created prior to November 2011

91688

NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.

Yes

Method Name A short description of the method used to perform the test

HPLC-Electrochemistry

Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name

Neurotransmitter Metabolites

Aliases Lists additional common names for a test, as an aid in searching

Neurotransmitter Metabolites FORWARD

Specimen Type Describes the specimen type needed for testing

CSF

Specimen Required Defines the optimal specimen. This field describes the type of specimen required to perform the test and the preferred volume to complete testing. The volume allows automated processing, fastest throughput and, when indicated, repeat or reflex testing.

Medical Neurogenetics collection kit (MML Supply T657) required.

Each collection kit contains 5 microcentrifuge tubes.

 

COLLECTION PROTOCOL

1)      CSF should be collected from the first drop into the tubes in

the numbered order. Fill each tube to the marked line with

the required volumes.

Tube 1:  0.5 mL

Tube 2:  0.5 mL

Tube 3:  1.0 mL (contains antioxidants necessary to protect

                                 the sample integrity)

Tube 4:  1.0 mL

Tube 5:  0.5 mL

- If samples not blood contaminated should be placed on dry

  ice at bedside

- If samples are blood contaminated, the tubes should immediately

  be centrifuged (prior to freezing) and the clear CSF transferred to

  new similarly labeled tubes, then frozen.

-Store samples at -80 until they can be shipped. 

2)       Complete Medical Neurogenetics, LLC request form. Include

test required, sample date, date of birth, current medications

and relevant history.

3)       Label tubes with patient name and ID number, leaving the tube

number viewable.

4)       Place samples inside a specimen transport bag and the Medical

Neurogenetics, LLC request form inside the pouch of the transport

bag.

        5)    Ship samples frozen on dry ice.

 

Specimen Minimum Volume Defines the amount of specimen required to perform an assay once, including instrument and container dead space. Submitting the minimum specimen volume makes it impossible to repeat the test or perform confirmatory or perform reflex testing. In some situations, a minimum specimen volume may result in a QNS (quantity not sufficient) result, requiring a second specimen to be collected.

3.5 mL

Reject Due To Identifies specimen types and conditions that may cause the specimen to be rejected

Specimens other than

CSF in special collection kit (MML supply T657)

Anticoagulants other than

NA

Hemolysis

NA

Thawing

Warm reject; Cold reject

Lipemia

NA

Icteric

NA

Specimen Stability Information Provides a description of the temperatures required to transport a specimen to the laboratory. Alternate acceptable temperature(s) are also included.

Specimen TypeTemperatureTime
CSFFrozen

Reference Values Describes reference intervals and additional information for interpretation of test results. May include intervals based on age and sex when appropriate. Intervals are Mayo-derived, unless otherwise designated. If an interpretive report is provided, the reference value field will state this.

Age           5HIAA              HVA             3-O-MD

(years)      (nmol/L)           (nmol/L)        (nmol/L)

 

0-0.2        208-1159           337-1299         <300

0.2-0.5      179-711            450-1132         <300

0.5-2.0      129-520            294-1115         <300

2.0-5.0         74-345             233-928          <150

5.0-10          66-338             218-852          <100

10-15           67-189             167-563          <100

Adults         67-140             145-324          <100

 

Interpretation performed by Keith Hyland, Ph.D.

       

Note: If test results are inconsistent with the clinical

presentation, please call our laboratory to discuss the case

and/or submit a second sample for confirmatory testing.

       

DISCLAIMER required by the FDA for high complexity clinical

laboratories: HPLC testing was developed and its performance

characteristics determined by Medical Neurogenetics. These

HPLC tests have not been cleared or approved by the U.S. FDA.

       

Test Performed By:  Medical Neurogenetics Lab

                               5424 Glenridge Drive NE

                               Atlanta, GA  30342

Interpretation Provides information to assist in interpretation of the test results

Recently, a cerebral folate deficiency syndrome has

been described.  The clinical picture is one of

developmental delay/regression, cerebellar ataxia,

with or without seizures, with or without autism.

This disorder is treatable with folinic acid.  If your

patient fits the clinical picture we can measure 5-

methyltetrahydrofolate in the CSF we already have if you

wish to add on this test.  Please see: Ramaekers VT, Blau N.

Cerebral folate deficiency, Dev Med Child Neurol.

2004 Dec;46(12):843-51. Cerebral folate deficiency

has also been described in mitochondrial disorders.

     

We now have biomarkers for folinic acid/pyridoxine

responsive seizures (Antiquitin, ALDH7A1) that appear on

our neurotransmitter metabolite chromatogram.

Day(s) and Time(s) Test Performed Outlines the days and times the test is performed. This field reflects the day and time the sample must be in the testing laboratory to begin the testing process and includes any specimen preparation and processing time required before the test is performed. Some tests are listed as continuously performed, which means assays are performed several times during the day.

Monday through Friday

Analytic Time Defines the amount of time it takes the laboratory to setup and perform the test. This is defined in number of days. The shortest interval of time expressed is "same day/1 day," which means the results may be available the same day that the sample is received in the testing laboratory. One day means results are available 1 day after the sample is received in the laboratory.

14 days

Maximum Laboratory Time Defines the maximum time from specimen receipt at Mayo Medical Laboratories until the release of the test result

16 days

Performing Laboratory Location The location of the laboratory that performs the test

Medical Neurogenetics, LLC

CPT Code Information Provides guidance in determining the appropriate Current Procedural Terminology (CPT) code(s) information for each test or profile. The listed CPT codes reflect Mayo Medical Laboratories interpretation of CPT coding requirements. It is the responsibility of each laboratory to determine correct CPT codes to use for billing.

82492 

LOINC® Code Information Provides guidance in determining the Logical Observation Identifiers Names and Codes (LOINC) values for the result codes returned for this test or profile.

Result IDReporting NameLOINC Code
Z08525-Hydroxyindoleacetic acid47544-2
Z0849Homovanillic acid40846-8
Z08503-O-methyldopa3496-7
Z0851Interpretation:In Process